Programmed death ligand‐1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder

Drugs blocking programmed death ligand‐1 (PD‐L1) have shown unprecedented activity in metastatic and unresectable bladder cancer. The purpose of the present study was to investigate the expression, clinical significance and association of PD‐L1 with tumor‐infiltrating lymphocytes (TIL) in resectable...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Pan, Wenwei, Yang, Meihua, Yang, Wenjuan, He, Wang, Chen, Xu, Bi, Junming, Jiang, Ning, Huang, Jian, Lin, Tianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361576/
https://www.ncbi.nlm.nih.gov/pubmed/30548363
http://dx.doi.org/10.1111/cas.13887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361576/
https://www.ncbi.nlm.nih.gov/pubmed/30548363
http://dx.doi.org/10.1111/cas.13887

Ejemplares similares